Artemis Investment Management LLP Initiates New Position in AbbVie Inc. (ABBV)
Artemis Investment Management LLP, a registered investment adviser, initiated a new position in AbbVie Inc. (NYSE:ABBV) during Q3 2026, according to its most recent 13F filing…
01Artemis Investment Management LLP purchased 497,086 AbbVie shares valued at $130.0 million in Q3 2026.
02AbbVie stock trades at $278.30 with a market capitalization of $410.1 billion.
0313F filings reflect holdings as of quarter-end and are filed up to 45 days later, so positions may have changed since filing.
04Healthcare sector institutional interest is driven by aging population demand and regulatory or pipeline developments.
05Large institutional positions like this are tracked by market participants as signals of smart money conviction.
Filing Details
Artemis Investment Management LLP, a registered investment adviser, initiated a new position in AbbVie Inc. (NYSE:ABBV) during Q3 2026, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 497,086 shares of the Healthcare company, valued at approximately $130.0M as of the filing date.
Market Context
AbbVie Inc.'s stock currently trades at $278.30 with a market capitalization of $410.1B.
A new institutional position can signal growing confidence in a company's prospects. When large asset managers like Artemis Investment Management LLP establish stakes, it often reflects months of due diligence and a conviction that the stock is undervalued or poised for growth. Retail investors often track 13F filings to identify stocks that institutional money is moving into.
Healthcare stocks have attracted institutional attention as an aging population drives long-term demand. AbbVie Inc. operates in a sector where regulatory developments and pipeline progress can significantly impact institutional positioning.
The size of this position — $130.0 million — places it among the more significant institutional holdings in AbbVie Inc. Large positions like this can influence trading dynamics and are closely watched by market participants tracking smart money flows.
Investors should note that 13F filings reflect holdings as of the end of the reporting quarter and are filed up to 45 days later. The position may have changed since the filing date. 13F data is most useful when analyzed alongside other signals such as insider transactions, analyst ratings, and fundamental trends.
A 13F filing is a quarterly SEC report required for institutional managers with over $100 million in assets. It discloses equity holdings, providing transparency into how firms like Artemis Investment Management LLP position their portfolios.